SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-026440
Filing Date
2011-05-06
Accepted
2011-05-05 18:11:57
Documents
10
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a11-9015_110q.htm 10-Q 795150
2 EX-31.1 a11-9015_1ex31d1.htm EX-31.1 9705
3 EX-31.2 a11-9015_1ex31d2.htm EX-31.2 9711
4 EX-32.1 a11-9015_1ex32d1.htm EX-32.1 7407
  Complete submission text file 0001104659-11-026440.txt   3316700

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT isis-20110331.xml EX-101.INS 421294
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isis-20110331.xsd EX-101.SCH 26009
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT isis-20110331_cal.xml EX-101.CAL 45511
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT isis-20110331_lab.xml EX-101.LAB 354180
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isis-20110331_pre.xml EX-101.PRE 153626
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT isis-20110331_def.xml EX-101.DEF 112017
Mailing Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 11816118
SIC: 2834 Pharmaceutical Preparations